NASDAQ: AXSM       Axsome Thera
Last Price Today's Change   Day's Range   Trading Volume
68.833   -2.548 (3.57%)  68.71 - 71.63  86,002


Avg Volume (4 weeks):303,855
4 Weeks Range:68.20 - 77.99
4 Weeks Price Volatility (%):
52 Weeks Range:20.48 - 109.94
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Axsome Therapeutics Inc is a United States-based healthcare service provider. As a pre-clinical therapeutics developer, the company attends primarily to central nervous system disorders such as Alzheimer's. Its product portfolio consists of novel drugs like the AXS-02 (disodium zoledronate tetrahydrate), which is an oral, non-opioid therapeutic for chronic pain and the AXS-05, which is a fixed-dose combination of dextromethorphan and bupropion. The AXS-02 addresses pain in over three conditions, such as complex regional pain syndrome, knee osteoarthritis and chronic low back pain. The AXS-05 on the other hand, treats resistant depression and agitation in patients with Alzheimer's disease. Both the products have passed the preclinical, Phase 1 and Phase 2 stages of development.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1307  4553  371  3173 

Top 10 Active Counters
 LK 1.38+1.38 
 SNAP 41.50-1.67 
 OAS 0.155-0.014 
 GRIL 2.11+0.58 
 AAPL 114.27-0.77 
 AAL 11.90-0.70 
 GE 7.415-0.215 
 SQQQ 22.67+1.07 
 AMTD 39.97-0.85 
 PGNX 4.10-0.425